Cargando…
Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care
Cardiovascular disease (CVD) complicates type 2 diabetes. Empagliflozin and liraglutide have demonstrated improved survival in patients with type 2 diabetes and established CVD. We assessed prevalence and standard of care of patients with type 2 diabetes and established CVD managed in primary care....
Autores principales: | Rungby, Jorgen, Schou, Morten, Warrer, Per, Ytte, Lars, Andersen, Gert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704655/ https://www.ncbi.nlm.nih.gov/pubmed/29276653 http://dx.doi.org/10.1097/XCE.0000000000000135 |
Ejemplares similares
-
Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide study
por: Jensen, Jesper, et al.
Publicado: (2023) -
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study
por: Thein, David, et al.
Publicado: (2020) -
Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014
por: Christensen, Diana Hedevang, et al.
Publicado: (2016) -
Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
por: Malmborg, Morten, et al.
Publicado: (2021) -
Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study
por: Schwartz, Brian, et al.
Publicado: (2022)